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Available online 5 June 2013In tumor microenvironment, interactions among multiple cell types are critical for cancer
progression. Secreted proteins are responsible for crosstalk among these cells within tumor
microenvironment. To elucidate the interactions of tumor and epithelia, we co-cultured colon
cancer cell line HT29 with normal human colonmucosal epithelial cell line NCM460 tomimic
tumor microenvironment in vitro and investigated the differential expression pattern of
secretome. A quantitative proteomics approach based on stable isotope labeling by amino
acids in cell culture (SILAC) and LC–mass spectrometry was used for secretome analysis.
Totally 45 proteinswere altered over 2-fold in co-cultured cellular supernatants between equal
amounts of NCM460 and HT29 cells, compared with mono-cultured conditions. These
differential secreted proteins involve in multiple tumor-associated biological functions. The
secretion level and acting pattern of acrogranin, IGFBP6 and vimentin were changed along
with different co-cultured cell number ratios between NCM460 and HT29 cells, simulating
early, middle or advanced stage of colon cancer. Therefore, a quantitative secretome profiling
based on a co-culture system can track secreted protein changes and their associated
biological roles between tumor and epithelia, which gives a new insight on communications
between tumor and epithelia as well as cancer biotherapy by inhibiting cell interactions.
Biological significance
Tumor microenvironment is a complex system and comprised of cancer cells and host
stromal cells. The growth and progression of tumor have been recognized were affected by
multidirectional interactions of secreted proteins (secretome), which were produced by the
cells within tumor microenvironment. Focus on general secreted molecules of living cells viaKeywords:
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52 J O U R N A L O F P R O T E O M I C S 8 9 ( 2 0 1 3 ) 5 1 – 7 0proteomic tools, is promising for investigating cell communication. Stable isotope labeling by
amino acids in cell culture (SILAC) is a metabolic labeling strategy for quantitative analysis,
which is gaining popularity because of its ease of implementation, the high quality of
quantitative data obtained, robustness and compatibility with existing experimental
workflows. Therefore, SILAC-based quantitative secretome analysis was employed for in-
vestigating interactions between epithelia and tumor by in vitro modulating colon cancer
microenvironment with established co-culture system, which simplified the complexity of
cancer microenvironment, also tracked secreted protein changes and their associated biological
roles between epithelia and cancer cells. A series of tumor associated secreted proteins was
quantitated and investigated in our study. So, the results give a new insight on communications
between tumor and epithelia as well as cancer biotherapy by inhibiting interactions of them.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Tumor microenvironment is comprised of neoplastic cells and
host stromal cells [1]. The expression of various proteins which
control theprogressionof cancerwas influencedby these cells [2].
Both tumors and stromal cells could secrete a series of proteins
including growth factors, proteinase and cytokines to regulate
tumor microenvironment [3]. For example, the vascular endo-
thelial growth factor was released by the tumors, which played a
key role in angiogenesis via promoted vascularization,maintains
proliferation and dissemination of tumors [4]. The epidermal
growth factor and transforming growth factor work as ligands
and trigger the activation of various oncogene transduction
pathways by binding with receptors that locate in extracellular
membrane, including PI3K/AKT, RAS/RAF/MAPK pathway, all of
them are closely associated with the occurrence and progression
of cancer [5]. The matrix metalloproteinases could digest the
extracellular matrix for tumor migration and invasiveness [6].
Cytokines could recruit inflammatory cells and maintain tumor
microenvironment [7] whereas stromal cells play double roles
during cancer progression. At early stage of cancer, they function
as defenders via releasing cytokines to inhibit tumor growth [8].
On the contrary, many factors including interleukins secreted by
surrounding tissues, could induce epithelial mesenchymal tran-
sition (EMT) of tumors at specific stages [9].
Currently, secretome which focuses on general secreted
molecules of living cells via proteomic tools, is promising for
investigating cell communication and discovery of cancer
biomarkers [10,11]. Secreted proteins influence adjacent cells
or distant organ via endocrine, paracrine and autocrine
pathways [12]. The key step of tumorigenesis is malignant
transformation of normal epithelial cells, which is induced by
the adjacent tumor cells [13].
The hallmarks of malignant transformation of epithelia are
the capabilities of invasion and metastasis [14]. Colorectal
cancer (CRC), also known as colon cancer, is the third most
common cancer worldwide, and one fourth of the patients with
CRChave an occurrence ofmetastasis and a 5 year survival rate
of <10% [15]. In many cases of colon cancer, the mutation of
tumor suppressor gene and oncogene is mainly responsible for
the malignant transformation of epithelia. For example, muta-
tions of RAS and BRAF have been proved to significantly induce
cell migration and invasion properties in colon cancer cells [16].
Nuclear accumulation of the transcriptional activator β-catenin
in CRC is mostly caused by the mutation of APC tumor
suppressor, which is associated with EMT of tumor cells [14].However, the interactional way between tumor and epithelial
cells is not completely clear. Furthermore, the roles of cell
communications between tumor cells and epithelia are not
known in tumor microenvironment, and their biological
functions of epithelia and tumor cells are still not clear during
tumorigenesis? These issues still remain to be elucidated. In
most cases, the information exchanges between epithelia and
cancer cells mainly via secreted proteins bymeans of autocrine
or paracrine [17]. Therefore, the secretome profiling of tumor
and epithelial cells within tumor microenvironment would
help to discover interactions among these cells, which largely
increases our understanding about the occurrence and devel-
opment mechanisms of neoplasia.
In our study, colon adenocarcinoma cell line HT29 and colon
epithelial cell line NCM460 were co-cultured by a transwell
system to simulate their interactions in tumor microenviron-
ment. Because the low abundance of secreted proteins in the
medium supernatants, a SILAC (stable isotope labeling by
amino acids in cell culture)-based quantitative technology
coupled with liquid chromatography (LC)–mass spectrometry
(MS) [18–20] was adopted to address the altered secretome
profiling under co-cultureswith HT29 andNCM460 cells. By this
approach, 41 proteins were greatly down-regulated and 4 were
up-regulated with 2-fold in co-cultured conditions with 1:1 cell
number ratio. Many altered secreted proteins including IGFBP6,
acrogranin, PA2G4, IGFBP2, stanniocalcin 2 and vimentin are
widely participated in various cancer-related biology events,
including proliferation, metastasis and metabolism of tumor
cells [21–26]. Our study put emphasis on the interactions via
secreted proteins between tumors and adjacent normal epithe-
lial cells, which could be considered as a potential target for
blocking colon cancer progression at early stage.2. Materials and methods
2.1. Cell culture
The colon cancer cell line HT29 is derived from human colon
adenocarcinoma grade II [27], NCM460 is a normal human
colon mucosal epithelial cell line [28]. They were both
purchased from American Type Culture Collection (ATCC)
and maintained in the Dulbecco's Modified Eagle's Medium
(DMEM) (Gibco, Gaithersburg, MD) supplemented with 10%
fetal bovine serum (FBS) (16000-044, Gibco, USA) at 37 °C in
humidified atmosphere with 5% (v/v) CO2.
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For SILAC experiment, HT29 and NCM460 cells were respective-
ly cultured in DMEM (89985, Thermo) with 10% dialyzed FBS
(26400, Gibco), which was supplemented with non-radioactive
13C6-lysine (13C6-Lys) (98%; 89988, thermo) replacing normal
unlabelled lysine at a concentration of 0.1 mg/ml. All cells were
routinely maintained at 37 °C in humidified air containing 5%
CO2. The culture media were changed every 3 days. Cells were
maintained in ‘labeled’ medium for at least 8 doubling times to
achieve >95% incorporation of 13C6-Lys. The stable isotope
labeling ratio was detected according to our previous reports
[19,29–32].
2.3. Co-culture conditions
To modulate the interactions between the two kinds of cell
lines, HT29 and NCM460 cells were co-cultured based on a
transwell system with 1:1 cell number ratio. In co-culture
system, 5 × 106 ‘unlabeling’ NCM460 cells were seeded into the
‘bottom’ chamber of a 75 mm-transwell plate and incubated
with 8 ml serum-free DMEM, meanwhile the same amounts of
‘unlabeling’ HT29 cells were also cultured with 8 ml serum-free
DMEM onto the top chamber of the transwell plate, and cells
were co-cultured for 48 h. In the mono-culture system, 5 × 106
13C6-Lys labeling NCM460 and the same amounts of 13C6-Lys
labeling HT29 cells were respectively cultured alone in 8 ml
serum-free 13C6-Lys labeling DMEM for 48 h.
In themimic case of early or advanced stage of colon cancer,
the mixed ratio of NCM460 and HT29 cells was designed at
3:1 and 1:3 respectively. Simply, the co-culture of NCM460
(7.5 × 106 cells/8 ml media) and HT29 (2.5 × 106 cells/8 ml
media) was regarded as early stage, while the mixture with
2.5 × 106 NCM460 cells and 7.5 × 106 HT29 cells was mimicked
an advanced stage of colon cancer. All of them were incubated
in the serum-freemedia for 48 h for targeted protein validation.
2.4. Secreted protein preparation
The conditionedmedium (CM) is designated here as the serum-
free medium which was used to incubate NCM460 or HT29
cells in the co-culture and mono-culture system. The CM was
collected by centrifugation at 1500 ×g for 3 min to remove cell
debris, following with a sterile filtration (pore size: 0.22 μm,
Millipore). With an addition of proteinase inhibitor (cocktail,
P-8340, sigma), the CM was concentrated by ultrafiltration
using a centrifugal filter device “Amicon Ultra-15” (UFC900324,
Millipore) with centrifugation at 4000 ×g for 2 h. Proteins
were precipitated with cold acetone at −20 °C overnight, and
collected by centrifugation with 13,000 g for 20 min at 4 °C. The
pellet was air-dried at room temperature, and resolved in
40 μml RIPA buffer (50 mM Tris–HCl pH 8.0, 150 mMNaCl, 0.1%
SDS, 0.5% sodium deoxycholate, 1.0% NP-40).
2.5. Protein in-gel digestion
Proteins were separated by 12% SDS-PAGE and stained with
coomassie to visualize gel bands. Ten obvious bands were
excised and cut into 1-mm3 slices. The gel was destained twice
with 100 mM NH4HCO3/50% acetonitrile (ACN) at 37 °C for30 min, and after being dehydrated and dried, gel slices were
digested with 10–20 μl mass spectrometry (MS)-grade trypsin
(V5280, Trypsin Gold, Promega, USA) at 37 °C overnight.
Peptides were extracted by ultrasonic with extraction solution
(50%ACN/5% trifluoroacetic acid) for twice. The combined
extraction was dried in a vacuum concentrator at room
temperature. The samples were then subjected to MS analysis.
2.6. Reverse LC–MS/MS
Protein was identified by LC–nanospray-MS/MS with LTQ-
OrbiTrap XL linear ion trap mass spectrometer (Thermo
Finnigan, San Jose, CA). Peptide samples were desalted on RP
trap columns (Zorbax 300 SB C18, Agilent Technologies, Palo
Alto, CA), and separated on an RP column (150 μm, 150 mm
length, Column Technology Inc.). The mobile phase A was 0.1%
formic acid in HPLC-grade water, and the mobile phase B was
0.1% formic acid in acetonitrile. The peptidemixturewas loaded
on the columns to separate with a flow rate of 2 μl/min by using
a linear gradient of 4%–50% B for 110 min, 50%–100% B from
110 min to 115 min and sustained at 100% B for 5 min.
Data-dependent MS/MS spectra were obtained simultaneously.
Each scan cycle consisted of one full MS scan in profile mode
followed by seven MS/MS scans in centroid mode.
2.7. MS data analysis
The MS data were processed by Maxquant software using
Andromeda (version 1.1.36) as the database search engine
[33,34]. The parameters for database searching were set as
following: Database, ipi.HUMAN.v3.87.fasta (September 27,
2011) from International Protein Index (IPI, 91464 sequences);
enzyme, trypsin; and an allowance of two missed cleavage.
Carbamidomethyl (C) was selected as a fixed modification, and
oxidation (M), acetyl (proteinN-term) and 13C6-Lys labelingwere
set as the variable modification. Initial peptide mass tolerance
was set to 7 ppm and fragment mass tolerance was 0.5 Da. The
false discovery rates (FDRs) of peptide and protein were both
set to 0.01, which ensure that protein identifications with
FDRs ≤ 1% (95% confidence) and at least one unique peptide of a
protein successfully detected were considered to be acceptable
[35].
2.8. ELISA assay
The secretion level of IGFBP6, acrogranin and vimentin in cell
culturewasmeasured by enzyme-linked immunosorbent assay
(ELISA). Protein concentrations were measured using Bio-Rad
protein assay (Bio-Rad, Hercules, California 94547, USA).
CM was added into a 96-well plate, which was pre-coated
with anti-IGFBP6 antibodies (sc13094, Santa Cruz, USA), anti-
acrogranin antibodies (6513-1, Epitomics, USA) or anti-vimentin
antibodies (sc373717, Santa Cruz, USA) respectively. After
incubation for 1 h at 37 °C and washing 5 times with PBST
(3.2 mM Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM NaCl,
0.05% Tween 20, pH 7.4), the secondary antibody was added to
the plate to incubate 1 h at 37 °C. Then the plate was washed 5
timeswith PBST, substrate buffer (0.006%H2O2 in 0.01 M acetate
buffer and 0.05% sodium nitroprusside, pH 3.3) was added to
incubate for 30 minat 37 °C, then reactionswere stoppedby 1 N
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(Multiskan Mk3, thermo) at 450 nm, with correction at 570 nm.
2.9. Western blot
Several protein expressions were detected by western blot.
Proteins were separated on a 12% SDS-PAGE gel and transferred
onto a PVDF membrane at 100 V for 1 h. Subsequently the
membrane was incubated in TBS/T buffer (20 mM Tris–HCl,
pH 7.6, 150 mM NaCl, 0.1% Tween-20) with 5% non-fat milk at
room temperature for 2 h. The specific primary antibodies,
including mouse-anti-vimentin (1:500, sc373717, Santa Cruz,
USA), rabbit-anti-acrogranin (1:1000, 6513-1, Epitomics, USA)
and rabbit-anti-IGFBP6 (diluted 1:500, sc13094, Santa Cruz,USA),
were diluted in TBST (50 mMTris–HCl, with 150 mMNaCl, 0.1%
Tween-20, pH 7.4) buffer to incubate PVDF membrane at 4 °C
overnight. The corresponding secondary antibody conjugated
horseradish peroxidase was subsequently incubated with
the PVDFmembrane for 60 min at room temperature. Signal
detection was performed with ECL reagent (Amersham
Biosciences, Piscataway, New Jersey, USA).
2.10. Immunofluorescence analysis
Immunofluorescence microscopy was performed with cells on
coverslips. For co-culture cells, which stained with antibodies
were previously seed on coverslips in the bottom chamber of
transwell, the other cells were plated on top chamber and were
incubated for 48 h. Then cells on the coverslips were fixed with
paraformaldehyde for 30 min. After fixation, cells were washed
with TBST twice and blocked in 1.5% BSA/TBST for 1 h at room
temperature. Then cells were respectively incubated with pri-
mary antibodies against vimentin (sc373717, Santa Cruz, USA)
and IGFBP6 (sc13094, Santa Cruz, USA) overnight at 4 °C. After
washed in TBST for 3 times, cells were incubated with TRITC-
conjugated secondary antibodies (ZF-0313, ZSGB-BIO) and FITC-
conjugated ones (ZF-0314, ZSGB-BIO) for 1 h and stained with
DAPI for 5 min. The images were viewed and recorded by
Olympus BX40 and SPOT Flex (Diagnostic Instruments, Version
4.5).
2.11. Statistical analysis
Data are presented as mean ± SD of 3 independent experi-
ments, SPSS 15 software package (SPSS, Inc., Chicago, IL) was
used for statistical analysis. Independent sample t test was
used for ELISA group analysis. Differences were considered
statistically significant at P < 0.05.Fig. 1 – The SILAC-based quantitative proteomics strategy was ap
system between cancer cells and epithelia.13C6-Lys labeled NCM
and “unlabeled” NCM460 and HT29 cells with same number wer
was separately collected from mono-culture and co-culture syste
mono-cultured NCM460 was mixed with co-cultured CM, and th
mono-cultured HT29 was mixed with the co-cultured CM, and it
were respectively separated on SDS-PAGE, proteins were identif
was shown as the expression level of proteins from sample 1, an
status of sample 2. Change ratio of a protein, also the differential
calculating the value of SILAC ratio1 plus SILAC ratio2 (SILAC rat3. Results
3.1. A co-culture model and MS quantification criteria
In order to modulate the interactions between HT29 and
NCM460 cells in vitro, they were co-cultured to investigate the
differential secretome based on a transwell system with 1:1
cell number ratio. The SILAC-based quantitative proteomics
strategy was applied in the in vitro co-culture system to
analyze cell interactions between cancer cells and epithelia
(Fig. 1). The workflow of this strategy was generally described
as following. The 13C6-Lys-labeling or unlabeling CM was
separately collected from mono-culture and co-culture sys-
tem after incubation for 48 h. The CM derived from
mono-cultured NCM460 was mixed with CM came from
co-culture system, and this was designated as sample 1.
Similarly, the CM of mono-cultured HT29 was mixed with the
co-cultured CM, and it was designated as sample 2. Prior to
LC–MS/MS analysis, both two sets of mixed CM samples were
concentrated by ultrafiltration and separated by SDS-PAGE
followed by protein in-gel digestion and MS identification.
The SILAC ratio was defined as the intensity ratio of 13C6-
Lys-labeling peptides versus the unlabeling ones. It was
averaged when several peptides were used to quantify a
protein. The SILAC ratio1 of sample 1 was shown as the relative
expression level of a secreted protein between 13C6-Lys-labeling
mono-cultured NCM460 versus co-cultured cells (NCM460/
co-culture). Similarly, SILAC ratio2, from sample 2, was repre-
sented as protein levels in condition of 13C6-Lys-labeling
mono-culturedHT29 versus co-cultured cells (HT29/co-culture).
Because the same number of NCM460 and HT29 cells was
respectively seeded both in each mono-culture model and in
either the top or bottom chamber of the co-culture, cell
amounts in the co-culture model were double times compared
with eachmono-culture. Theoretically, the concentrations of all
secreted proteins in co-culture systemwere almost equal to the
sum of secreted proteins from two groups of mono-cultured
cells. Therefore, for a protein, its total SILAC ratio, namely the
sum of SILAC ratio1 plus SILAC ratio2 (SILAC ratio 1 + SILAC
ratio2) was near 1 as no expression change happened after
co-cultured. If the sum of SILAC ratio1 plus SILAC ratio2 was
over than 1, which indicated that the protein expression was
down-regulated after co-culture. On the contrary, as the sum of
SILAC ratio1 plus SILAC ratio2 was less than 1, it meant an
up-regulation of a protein after co-cultured, and the increased
foldwas calculated by the reciprocal of the sum (1 / (SILAC ratio
1 + SILAC ratio 2)).plied to analyze differential secreted proteins of a co-cultured
460 and HT29 cells were mono-cultured for 48 h respectively,
e co-cultured for 48 h. The 13C6-Lys-labeling or unlabeling CM
m after incubation for 48 h. The CM derived from
is was designated as sample 1. Meanwhile, the CM of
was designated as sample 2. Then sample 1 and sample 2
ied by LC–MS/MS and data were analyzed. The SILAC ratio 1
d the SILAC ratio2 was represented as protein expression
secretion level of a protein after co-cultures was estimated by
io 1 + SILAC ratio 2). CM: conditioned medium.
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secretion level of a protein after co-cultures was estimated by
calculating the value of SILAC ratio1 plus SILAC ratio2 (SILAC
ratio 1 + SILAC ratio 2) as above, which should be normalized
with a correction factor based on the SILAC quantification. In
our system, 5 × 106 mono-cultured NCM460 cells could release
100.69 μg of proteins in the CM, while 59.97 μg of secreted
proteins was obtained in the same amounts of HT29 cells.
Meanwhile 139.74 μg of proteins was detected in CM derived
from co-culture system of these two cell lines. The resultsFig. 2 – The proteins identified in co-culture. (A) Proteins identified
themixed CM coming from sample 1, 203 of themwere quantified
sample 2, and 221 of them were quantified with 13C6-lys labeled
quantified in both two samples. (B, C) Ratio distributions of samp
of altered proteins in co-culture. A total of 101 proteins was iden
changed proteins (changes > 2.0-fold). 4 of these quantitated pro
down-regulated >2-fold after co-culture.ensure the reliability of our approach, and that the value 1.15
((100.69 + 59.97)/139.74) was taken as a correction factor for
protein concentration in SILAC quantification. Usually, the
change ratio with 1.3–2.0 has been used as a cut-off for both
statistical and biological significance [18,36–38]. In our study,
the average standard deviation (SD) of SILAC ratios for 101
quantified proteins was 0.25 and 0.18 for sample 1 and sample
2 respectively. And a significantly changed protein was
defined as its fold change was 5 times higher than the average
SD value (0.21) according to our previously establishedin conditionedmedium (CM). 381 proteins were identified in
by 13C6-lys labeled sequence. 496 proteins were identified in
sequence. Taken together, 101 proteins were simultaneously
le 1 and sample 2 exhibit a normal distribution. (D) Summary
tified and quantitated by SILAC, 45 of them were regarded as
teins were up-regulated >2-fold, 41 proteins were
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of a protein over 2 was categorized as up- or down-regulation
after co-culture in the condition of 1:1 cell number ratio.
3.2. Identification of secreted proteins
The incorporation rate of 13C6-Lys in NCM460 and HT29 cells
reached 95% after eight cell doubling. Totally 381 proteins
were identified in sample 1, meanwhile 496 proteins were
detected in sample 2, and 101 proteins were both identified
with good quantitative data in both case (Fig. 2A). In sample 1,
11 proteins of SILAC ratios were less than 0.1, 26 proteins were
changed between 0.1 and 0.5, 34 proteins altered between 0.51
and 1.0, 33 proteins varied from 1.01 to 2.0 and 6 proteins were
changed more than 2 times (Fig. 2B). However, in sample 2, 6
proteins with SILAC ratios were less than 0.1, 23 proteins
changed from 0.1 to 0.5, 24 proteins altered between 0.51 and
0.1, 30 proteins varied from 1.01 to 2.0, 19 proteins altered
from 2.01 to 6.0, and 8 proteins changed more than 6 times
(Fig. 2C). Statistical analysis by t test indicated that SILAC ratio
of each comparison nearly exhibited a normal distribution for
the two sets of samples (P < 0.05).
Among the identified proteins in our study, CD44 expression
was used for internal control. CD44 is a membrane protein
shedding, a generalized secreted protein [40], which functions
as cell adhesion and promotes tumor invasion [41]. As a surface
marker of cancer cells, CD44mainly expresses in a colon cancer
cell line HT29 [42,43], but rarely exists in the normal colon
epithelia cell line NCM460 [44]. Consistently, from the SILAC
quantification results, the SILAC ratio1 of CD44 was 0.01 in the
medium supernatants of mono-cultured NCM460 versus
co-cultured model, while the SILAC ratio 2 was 1.07 in the CM
ofmono-cultured HT29 versus the co-culturemodel. Therefore,
CD44 expression almost was not changed in co-culture condi-
tions compared with two monocultures. This indicated that in
our study, the same amounts of cells for identification standard
were credible, and that protein fold changeover 2 categorized as
up- or down-regulated was reasonable. According to the quan-
titative standards, as summarized in Table 1, 4 proteins were
up-regulated over 2-fold in co-culture compared with mono-
culture system, whereas 41 proteins were down-regulated over
2-fold, nine of these were highly down-regulated (>6.0-fold)
after co-cultured.
As several examples, the decreased protein IGFBP6,
acrogranin and an increased protein cytokeratin-9 were
shown their representatively quantitative peptides with MS
spectra. For example, one isotope labeling peptide with a
sequence (APAVAEENPK) of IGFBP6 (m/z 513.26 versus m/z
516.27) was used for quantitative analysis (Fig. 3A). The SILAC
ratio1 was close to zero from the sample 1 (NCM460/co-culture),
while SILAC ratio2 was 2.48 (6.73 × 106 counts / 2.71 × 106
counts = 2.48) derived from isotope peptide intensity ratio
of sample 2 (HT29/co-culture). Therefore, the change ratio of
IGFBP6 expression between two mono-cultures and co-culture
(SILAC ratio1 + SILAC ratio2) was 2.48, which indicated that
IGFBP6 was greatly inhibited after co-culture. Similarly,
one representative isotope labeling peptide with a sequence
(GSEIVAGLEK) for acrogranin (m/z 501.77 versus m/z 504.77)
quantification was shown in Fig. 3B. The SILAC ratio1 was less
than 0.01 and SILAC ratio2 was 1.34 (8.72 × 105 counts /6.51 × 105 counts = 1.34), from which the expression of
acrogranin was 1.35-fold down-regulated in the CM of co-
culture system compared with the two mono-cultures.
Cytokeratin-9 was one of the increased proteins after
co-culture, which mainly locates in the cell membrane, and it
is classified as a general secreted protein. One unique isotope
labeling peptide (QEYEQLIAK) of cytokeratin-9 (m/z561.29 versus
m/z561.31) was used for quantification (Fig. 3C). SILAC ratio1 and
ratio2 of this protein were 0.18 (0.97 × 105counts / 5.25 × 105
counts = 0.18) and 0.08 (0.61 × 105 counts /7.36 × 105 counts =
0.08) respectively, which suggests that the change ratio of
cytokeratin-9 between two mono-cultures and co-culture was
0.26, and it meant about 4-fold up-regulation of this protein in
co-culture. It was noted that the quantification results of MS
spectra were different from Table 1. This is because the change
ratio of protein was comprehensively decided by all of identified
peptides with isotope labeling. Additionally, the quantification
softwareMaxquantwould automaticallynormalize results ofMS
spectra by a special arithmetic conversion, and then the final
quantification data were obtained.
3.3. Cellular localization, biological function and pathway
analysis of the differential secreted proteins
The differential expressed proteins were divided into various
group based on their subcellular locations and biological
functions according to the GO terms. Most proteins participate
in metabolism (31%) and catabolic process (20%). About 4% of
the proteins play roles in signal transduction, 4% is involved in
cell proliferation and apoptosis, as well as 9% of the proteins
take part in cytoskeleton reorganization (Fig. 4A, Table 2).
Recently, it has been clear that many of the oncogene
signaling pathways regulated by tumor microenvironment
have profound effects on cancer cell metabolism [45]. This
conclusion is also supported by our SILAC data from several
altered enzymes involved in glycolytic metabolism, which
included 2-phospho-D-glycerate hydrolyase, malate dehydro-
genase, triosephosphate isomerase, L-lactate dehydrogenase
A chain and carbonate dehydratase II to be identified during
down-regulation after co-culturing. Increasing the level of
glycolysis for ATP generation in cancer cells has been clearly
elucidated [46]. The down-expression of these glycolysis
associated enzymes at the middle stage of colon cancer is
hypothesized to be a common mechanism of organism to
defend malignant transformation of epithelia. Therefore, in
the initial development phase of tumor, normal epithelial
cells could decrease cell metabolism by down-regulation of
metabolic enzymes to inhibit tumor cell growth.
Furthermore, many other proteins function as enzymes for
catabolic process that involve in tumor progression [47,48].
Lipoprotein lipase, mainly locating in cell membrane, was
detected to increase in the CM of co-culture system (Table 2).
Lipoprotein lipase catalyzes the hydrolysis of plasma triglycer-
ide, serum triglyceride levels are linked with the risk of
development of cancer and mutation of lipoprotein lipase gene
increases cancer risk [49]. The SILAC ratio1 and SILAC ratio2 of
lipoprotein lipase were 0.33 and 0.02 respectively (Table 1),
namely, in co-cultured conditions lipoprotein lipase was
up-regulated to about 3-fold compared with mono-cultures.
And this result suggested that as early or middle stage of colon
Table 1 – Altered proteins were identified by SILAC in the conditioned medium.
Protein ID Protein names Gene
name
Unique
peptides
Sequence
coverage [%]
Protein
score
MW
[kDa]
SILAC
ratio1 a
SILAC
ratio2b
Fold
changec
Down-regulated proteinsd IPI00008780 Stanniocalcin-2 STC2 5 19.9 170.6 33.25 0.01 ± 0.001 2.28 ± 0.71 2.01 ↓
IPI00072377 HLA-DR-associated protein I ANP32B 4 17.9 231.5 33.49 1 ± 0.022 1.31 ± 0.01 2.01 ↓
IPI00784119 Vacuolar proton pump subunit S1 ATP6AP1 1 1.9 199.6 52.03 0.77 ± 0.32 1.54 ± 0.03 2.01 ↓
IPI00219217 L-lactate dehydrogenase heart subunit LDH-B 13 43.1 185.5 34.64 0.01 ± 0.001 2.31 ± 1.7 2.02 ↓
IPI00291922 Macropain zeta chain PSMA5 6 36.1 205.0 26.41 0.97 ± 0.01 1.35 ± 0.13 2.02 ↓
IPI00000874 Natural killer cell-enhancing factor A PRDX1 2 9 131.3 22.11 1.08 ± 0.01 1.31 ± 0.05 2.01 ↓
IPI00604620 Nucleolin NCL 3 5.6 153.9 76.613 2.18 ± 0.15 0.24 ± 0.04 2.1 ↓
IPI00217975 Lamin-B1 LMNB1 9 14.8 151.5 66.408 1.16 ± 0.44 1.28 ± 0.24 2.12 ↓
IPI00014898 Hemidesmosomal protein PLEC 10 2 136.1 531.78 2.06 ± 0.05 0.45 ± 0.08 2.21 ↓
IPI00220301 1-Cys peroxiredoxin PtrcPrx1-Cys 5 28.6 187.1 25.04 1.15 ± 0.06 1.37 ± 0.12 2.21 ↓
IPI00028911 Alpha-dystroglycan DAG1 5 8.2 189.6 97.44 0.25 ± 0.11 2.36 ± 1.13 2.29 ↓
IPI00465248 2-phospho-D-glycerate hydro-lyase ENO2 6 18.4 193.3 47.17 1.09 ± 0.09 1.53 ± 0.07 2.28 ↓
IPI00022959 CDw113 PVRL3 3 7.7 151.9 61 0.01 ± 0.001 2.56 ± 0.03 2.23 ↓
IPI00419249 Macropain subunit C8 PSMA3 12 45.5 190.4 28.433 1.03 ± 0.11 1.67 ± 0.6 2.35 ↓
IPI00291006 Malate dehydrogenase MDH2 1 3 190.6 35.5 0.65 ± 0.06 2.15 ± 0.83 2.43 ↓
IPI00465431 35 kDa lectin LGALS3 4 13.2 129.1 26.15 1.46 ± 0.21 1.63 ± 0.08 2.69 ↓
IPI00003865 Heat shock 70 kDa protein 8 HSPA8 20 36.1 178.5 70.9 2.03 ± 0.5 1.09 ± 0.34 2.71 ↓
IPI00215965 Helix-destabilizing protein HNRNPA1 2 6.7 131.2 38.845 0.99 ± 0.16 2.15 ± 0.4 2.73 ↓
IPI00009950 Glycoprotein GP36b LMAN2 9 32.9 181.6 40.23 0.03 ± 0.03 3.18 ± 0.78 2.79 ↓
IPI00178440 Elongation factor 1-beta EEF1B2 2 8.9 158.6 24.763 0.99 ± 0.25 2.61 ± 0.35 3.13 ↓
IPI00008530 60S acidic ribosomal protein P0 RPLP0 2 6.9 179.7 34.27 1.26 ± 0.08 2.35 ± 1.04 3.14 ↓
IPI00735319 HLA-DR-associated protein II ANP32B 2 7.9 194 34.882 2.33 ± 0.62 1.31 ± 0.69 3.17 ↓
IPI00797126 Nascent polypeptide-associated complex
subunit alpha
NACA 3 4.5 261.5 94.68 1.24 ± 0.47 2.63 ± 0.19 3.37 ↓
IPI00465028 Triosephosphate isomerase TPI1 10 51 182.7 30.8 0.28 ± 0.13 3.77 ± 0.52 3.52 ↓
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IPI00418471 Vimentin VIM 4 11.4 108.4 53.65 3.78 ± 0.36 0.28 ± 0.21 3.53 ↓
IPI00947127 L-lactate dehydrogenase A chain LDHA 5 14.1 147 39.84 1.35 ± 0.09 2.72 ± 0.08 3.54 ↓
IPI00218414 Carbonate dehydratase II CA2 1 6.2 168.9 29.25 0.79 ± 0.12 3.38 ± 2.27 3.63 ↓
IPI00807557 PA2G4 protein PA2G4 4 8.1 131.9 45.15 1.24 ± 0.06 2.94 ± 1.01 3.63 ↓
IPI00219018 Glyceraldehyde-3-phosphate dehydrogenase GAPDH 8 39.1 181.7 36.05 0.09 ± 0.01 4.27 ± 2.93 3.8 ↓
IPI00396485 Elongation factor 1-alpha 1 EF1-alpha 5 11.5 135.7 50.14 1.41 ± 0.19 2.98 ± 0.56 3.82 ↓
IPI00297284 Insulin-like growth factor-binding protein 2 IGFBP2 7 22.3 166.7 35.14 0.01 ± 0.001 5.23 ± 2.59 4.56 ↓
IPI00549725 BPG-dependent PGAM 1 PGAM1 19 73.6 213.8 28.8 1 ± 0.17 4.26 ± 1.21 4.57 ↓
IPI00296713 Acrogranin GRN 4 8.3 152.9 63.544 0.07 ± 0.05 6.15 ± 2.17 5.41 ↓
IPI00003590 Quiescin Q6 QSOX1 14 24 171 82.6 0.02 ± 0.01 6.35 ± 0.72 5.54 ↓
IPI00219825 Prosaposin PSAP 13 24.2 149.2 61.9 0.01 ± 0.001 7.16 ± 1.92 6.23 ↓
IPI00171411 Golgi membrane protein 1 GOLM1 1 3.4 176.1 46.27 0.01 ± 0.002 7.24 ± 1.25 6.3 ↓
IPI00298520 Archain 1 ARCN1 1 2 183.6 61.63 2.24 ± 0.87 5.23 ± 2.59 6.5 ↓
IPI00410487 Twisted gastrulation protein homolog 1 TWSG1 3 15.2 168.4 25 0.02 ± 0.005 9.15 ± 0.93 7.97 ↓
IPI00745190 c-Kit ligand KITLG 3 10.6 166.2 30.85 0.01 ± 0.001 9.17 ± 2.95 7.98 ↓
IPI00032292 Erythroid-potentiating activity TIMP1 7 47.8 181.8 23.17 0.03 ± 0.005 10.77 ± 0.58 9.39 ↓
IPI00029235 Insulin-like growth factor-binding protein 6 IGFBP6 5 31.7 143.5 25.32 0.01 ± 0.001 12.32 ± 1.73 10.72 ↓
Up-regulated proteinse IPI00220327 67 kDa cytokeratin KRT1 10 31.4 184.2 66 0.01 ± 0.001 0.03 ± 0.012 33.3 ↑
IPI00019359 Cytokeratin-9 KRT9 11 23.4 172.6 62.1 0.03 ± 0.01 0.04 ± 0.02 16.67 ↑
IPI00166729 Zinc-alpha-2-glycoprotein AZGP1 2 9.4 158 34.26 0.01 ± 0.004 0.07 ± 0.01 14.29 ↑
IPI00027847 Lipoprotein lipase LPL 4 13.3 208 53.16 0.33 ± 0.06 0.02 ± 0.001 3.3 ↑
Notes: All quantitative data were recorded as mean ± SD.
a The mean SILAC ratio of protein expression in the conditioned medium of mono-cultured NCM460 versus co-culture cells.
b The mean SILAC ratio of protein expression in the conditioned medium of mono-cultured HT29 versus co-culture cells.
c Calculated by the SILAC ratio1 plus SILAC ratio2 and corrected by 1.15 (a correction factor), the number represents a mean fold change of a protein after co-culture.
d The fold change of down-regulated protein after co-cultured, which was calculated from the sum of SILAC ratio1 plus SILAC ratio2.
e The fold change of up-regulated protein after co-cultured, which was calculated by the reciprocal of the sum of SILAC ratio1 plus SILAC ratio2.
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60 J O U R N A L O F P R O T E O M I C S 8 9 ( 2 0 1 3 ) 5 1 – 7 0cancer, triglyceride concentration would be down-regulated by
up-regulating lipoprotein lipase expression to decrease the risk
of cancer occurrence.Peroxiredoxin is a ubiquitous family of antioxidant en-
zyme that not only controls peroxide levels via mediating
signal transduction in mammalian cells but also up-regulates
Fig. 3 – Quantitative analysis of the expression of IGFBP6, acrogranin and cytokeratin-9 with MS andMS/MS spectra. The SILAC
ratio1 for sample 1 (mono-cultured NCN460 versus co-culture) and SILAC ratio2 of sample 2 (mono-cultured HT29 versus
co-culture) were respectively calculated by peak intensity ratio of “labeled” (heavy) peptide versus “unlabeled” (light) one. The
change ratio of secreted proteins after co-culture was obtained by SILAC ratio1 plus SILAC ratio2. (A): MS and MS/MS spectra of
a unique isotope labeling peptide (m/z 513.26, m/z 516.27) “APAVAEENPK” of IGFBP-6 from sample 1 and sample 2. (B) MS and
MS/MS spectra of a unique isotope labeling peptide (m/z501.77/504.77) “GSEIVAGLEK” of acrogranin. (C) MS andMS/MS spectra
of a unique isotope labeling peptide (m/z 561.29/564.31) “QEYEQLIAK” of cytokeratin-9 from sample 1 and sample 2. Z was
charge number; K was the abbreviation of 13C6-Lys.
61J O U R N A L O F P R O T E O M I C S 8 9 ( 2 0 1 3 ) 5 1 – 7 0its expression in various cancer to increase the stress
resistance of cancer cells [50]. The ratio of mono-culture
versus co-culture was 2.21, this indicated that down-
expression of peroxiredoxin in co-culture CM probably
inhibited the growth of tumor progression of colon cancer.
In addition to the metabolism and catabolism process,
most of the identified proteins also participated in other
various biological events and regulated tumor microenviron-
ment. Prosaposin, inhibiting tumor metastasis by stimulation
of P53 and Tsp1 [51], was found to decrease 6.29-fold in the
co-cultured CM. Several signal proteins, including helix-
destabilizing protein and twisted gastrulation protein homo-
log 1 etc, were highly inhibited in the co-culture system
(Table 2). Twisted gastrulation protein participates in the
regulation of cell immunity, and helix-destabilizing protein
unwinds four-way DNA junctions, both of them function as
signal regulator tomediate cell proliferation and development
[52,53].
Other quantitative proteins, for example, cytokeratin-9,
one of the up-regulation expressed protein after co-culture, its
SILAC ratio1 and ratio2 were 0.03, 0.04 respectively (Table 1).
The data suggested that mono-cultured HT29 or NCM460 cells
barely secreted cytokeratin-9, but by culturing them together,both of these two kinds of cell lines would strongly express
cytokeratin-9. The similar results had been reported in an in
vitro model of lung cancer microenvironment [9].
Most of the altered proteins in CM are multifunctional
secreted factors and take part in a series of tumor associated
biological events as described above. From quantitative re-
sults, large numbers of proteins that promote tumorigenesis
were found down-regulated in the co-culture system, which
indicated that in the condition of 1:1 cell number ratio
between tumor cells and epithelia (imitating a middle stage
of colon cancer) in the microenvironment, the dominated
state of organism was inhibiting the development of cancer.
The proteins were found to be widely located in cytoplasm
(36%), cell membrane (24%), nucleus (13%) and others (7%)
(Fig. 4B). As we know, proteins are secreted mainly via three
different ways to be released out. In our identified proteins,
20% of the proteins were classically secreted proteins with
signal peptides via ER–Golgi pathway, and 36% of the
proteins were non-classically secreted proteins without
signal peptides, including a direct translocation of proteins
across plasmamembrane, releasing via exosomes derived from
multivesicular bodies or lysosomal secretion. In addition, 24%
of the proteins were located in the extracellular membrane
Fig. 4 – Functional analysis for altered proteins after co-culture. (A) 45 changed proteins were classified according to biological
functions. (B) These proteins weremainly located in cytoplasm (36%), membrane (24%), and nucleus (13%). 20% of the identified
proteins were typical secreted proteins with signal peptides. (C, D) Interaction analysis by bioinformatics. IGFBP6, vimentin
and acrogranin were found tightly linked with a series of tumor associated proteins including IGF1, cathepsin and PICK1 using
a software tool STRING. GRN was a gene name of acrogranin.
62 J O U R N A L O F P R O T E O M I C S 8 9 ( 2 0 1 3 ) 5 1 – 7 0which could be shed to the medium supernatants, which were
also regarded as generalized secreted proteins. To ensure cell
vitality, cell staining was performed with trypan blue to
estimate the number of dead cells in the serum-free medium.
There were less than 5% dead cells in the serum-free medium
for 24 h starvation, with no difference compared with normal
growth conditions.
As for the significant changes of the secreted proteins,
IGFBP6, vimentin and acrogranin were selected as candidates
for investigating the intrinsic interactionof theseproteins based
on the online software STRING (Fig. 4C–D). IGFBP6 and vimentin
were linked together with insulin-like growth factor (IGF) 1 and
IGF2, and IGF systemhas been implicated in cancer progression
[54]. The network interaction of these proteins profoundly
influences the development of colon cancer. Acrogranin was
found to have an interrelationship with secreted proteins
including cathepsin A, vascular endothelial growth factor
receptor (VEGFR) and cyclin T1. Cathepsin A plays a role in the
malignant transformation and metastatic dissemination of
cancer [55], and VEGFR and cyclin T1 regulate vascularization
and tumor growth [56,57]. Bioinformatics analysis suggestedthat IGFBP6, vimentin and acrogranin interact with another
tumor associated proteins and form a coactive regulative
system to mediate tumor microenvironment.
3.4. Functional analysis of acrogranin, vimentin and
IGFBP6 in the co-culture model
3.4.1. The secretion level of acrogranin was affected by
interactions of cancer cells and epithelia
Acrogranin, which functions as a classical secreted protein
and participates in cancer progression, was selected as a
candidate factor to validate SILAC–MS quantification results
and detect its expression by biochemical analysis. Concentra-
tion of acrogranin in mono-cultured CM and co-cultured
model was compared by ELISA assay (Fig. 5A). Co-cultured
CM was collected from co-incubated supernatant of NCM460
and HT29 together (NCM460:HT29) for 48 h, each mono-
cultured CM was respectively derived from mono-cultured
NCM460 and HT29 for 48 h incubation. In order to keep same
quantitative conditions with previous SILAC–MS analysis, the
CM mixture of two mono-cultures (NCM460 + HT29), was also
Table 2 – Cluster analysis of the changed proteins.
Biological process Protein ID Protein name Cellular
location
MW
[kDa]
Fold
change
Metabolic and synthesis
process(14)
IPI00008780 Stanniocalcin-2 Secreted 33.25 2.01 ↓
IPI00219217 LDH heart subunit Cytoplasm 34.64 2.02 ↓
IPI00465248 2-phospho-D-glycerate hydrolyase Cytoplasm 47.17 2.28 ↓
IPI00291006 Malate dehydrogenase Cytoplasm 35.5 2.43 ↓
IPI00465028 Triosephosphate isomerase Nucleus 30.8 3.52 ↓
IPI00218414 Carbonate dehydratase II Cytoplasm 29.25 3.63 ↓
IPI00296713 Acrogranin Secreted 63.544 5.41 ↓
IPI00003590 Glyceraldehyde-3-phosphate dehydrogenase Secreted 82.6 5.54 ↓
IPI00171411 Golgi membrane protein 1 Membrane 46.27 6.3 ↓
IPI00029235 Insulin-like growth factor-binding protein 6 Secreted 25.32 10.72 ↓
IPI00297284 Insulin-like growth factor-binding protein 2 Secreted 35.14 4.56 ↓
IPI00009950 Glycoprotein GP36b Membrane 40.23 2.79 ↓
IPI00735319 HLA-DR-associated protein II Membrane 34.882 3.17 ↓
IPI00072377 HLA-DR-associated protein I Membrane 33.49 2.01 ↓
Enzyme and catabolic
process(9)
IPI00784119 Vacuolar proton pump subunit S1 Others 52.03 2.01 ↓
IPI00291922 Macropain zeta chain Nucleus 26.41 2.02 ↓
IPI00220301 1-Cys peroxiredoxin Cytoplasm 25.04 2.21 ↓
IPI00419249 Macropain subunit C8 Nucleus 28.433 2.35 ↓
IPI00027847 Lipoprotein lipase Membrane 53.16 3.3 ↑
IPI00000874 Natural killer cell-enhancing factor A Others 22.11 2.01 ↓
IPI00219018 Quiescin Q6 Cytoplasm 36.05 3.8 ↓
IPI00947127 L-lactate dehydrogenase A chain Cytoplasm 39.84 3.54 ↓
IPI00219217 L-lactate dehydrogenase heart subunit Cytoplasm 34.64 2.02 ↓
Cell fate(4) IPI00217975 Lamin-B1 Membrane 66.408 2.12 ↓
IPI00028911 Alpha-dystroglycan Membrane 97.44 2.29 ↓
IPI00219825 Prosaposin Cytoplasm 61.9 6.23 ↓
IPI00745190 c-Kit ligand Membrane 30.85 7.98 ↓
Cytoskeleton(4) IPI00418471 Vimentin Cytoplasm 53.65 3.53 ↓
IPI00465431 35 kDa lectin Secreted 26.15 2.69 ↓
IPI00019359 Cytokeratin-9 Membrane 62.1 16.67 ↑
IPI00220327 67 kDa cytokeratin Membrane 66 33.3 ↑
Transport protein(2) IPI00032292 Erythroid-potentiating activity Secreted 23.17 9.39 ↓
IPI00166729 Zinc-alpha-2-glycoprotein Secreted 34.26 14.29 ↑
Protein modification and
synthesis(3)
IPI00003865 Heat shock 70 kDa protein 8 Cytoplasm 70.9 2.71 ↓
IPI00178440 Elongation factor 1-beta Nucleus 24.763 3.13 ↓
IPI00396485 Elongation factor 1-alpha 1 Nucleus 50.14 3.82 ↓
Adhesion and migration(2) IPI00014898 Hemidesmosomal protein Others 531.78 2.21 ↓
IPI00022959 CDw113 Membrane 61 2.23 ↓
Transcription(1) IPI00807557 PA2G4 protein Cytoplasm 45.15 3.63 ↓
Angiogenesis(1) IPI00604620 Nucleolin Cytoplasm 76.61 2.1 ↓
Signal protein(2) IPI00215965 Helix-destabilizing protein Nucleus 38.85 2.73 ↓
IPI00410487 Twisted gastrulation protein homolog 1 Secreted 25 7.97 ↓
Others(3) IPI00008530 60S acidic ribosomal protein P0 Cytoplasm 34.27 3.14 ↓
IPI00797126 Nascent polypeptide-associated complex subunit alpha Cytoplasm 94.68 3.37 ↓
IPI00549725 BPG-dependent PGAM 1 Cytoplasm 28.8 4.57 ↓
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secretion changes between twomono-cultures and co-cultures.
Meanwhile 20 μg of protein respectively from cell lysate and CM
was separately collected for western blot analysis.
As a result, the concentration of acrogranin in co-cultured
CM (NCM460:HT29) was significantly decreased compared
with either mono-cultured HT29 or the CM mixture of two
mono-cultures (NCM460 + HT29) (P < 0.05) (Fig. 5A). However,
the secretion of acrogranin was very little in mono-cultured
NCM460 cells. These ELSIA results directly verified the SILAC
quantification of acrogranin between mono-culture and
co-cultures. In our study, the SILAC ratio1 of acrogranin was
only 0.07, which indicated that the secretion level of
acrogranin was too little to detect in NCM460 cells. This was
validated in mono-cultured NCM460 cells. While the SILACratio2 of acrogranin was high to 6.15, this showed that the
protein level of acrogranin was much highly secreted by
mono-cultured HT29 cells (Fig. 5A, B). According to the
comparison of the SILAC ratio1 and SILAC ratio2, acrogranin
was found to decrease with 5.4 folds in the co-culture model
(Table 1), which was mainly due to its great down-regulation
from HT29 cells. Therefore, based on SILAC-based protein
quantification results, not only secreted protein expression
pattern could be detected, but also interactions between two
adjacent groups of cells could be elucidated clearly [58].
Correspondingly, a down-regulatedexpression of acrogranin
was also observed in cellular lysate of HT29 cells after
co-culture, whereas nearly no acrogranin existed in cell lysate
of NCM460 cells in same conditions (Fig. 5C). It is worth to be
noted that β-actinwasmarkedly expressed in cell lysate but not
Fig. 5 – The expression level of acrogranin in co-cultures. (A) ELISA analysis of acrogranin in the CM frommono-cultured NCM460,
mono-culturedHT29,mixture of these twomono-cultures and co-culturemodel.Themono-culturedCMcame frommono-cultured
NCM460 andmono-culturedHT29 for 48 h incubation, themixturemono-culturedCMcame from themixedmediumsupernatants
of these twomono-cultured cells that havebeen incubated for 48 h respectively (NCM460 + HT29), the co-culturedCMwas collected
with the incubation ofNCM460 andHT29 together for 48 h (NCM460:HT29). (B) The secretionof acrograninwas detected bywestern
blot. 20 μg of the proteins extracted frommono-cultured or co-cultured CMwere loaded in each lane. (C) The expression of
acrograninwas detected bywestern blot. 20 μg of proteins extracted fromcell lysates, collected frommono-cultured or co-cultured
NCM460 and HT29 respectively was loaded in each lane. (D) The expression and location of acrogranin (green) were shown in
mono-cultured NCM460 and co-cultured cells in phase-contrast microscopy image. (E) The expression and location of acrogranin
(green) were shown in mono-cultured HT29 and co-cultured cells in phase-contrast microscopy image. (F) The secretion of
acrograninwasdetectedbywestern blot. 80 μgofproteinswasextracted todetect respectively fromco-culturedCMofNCM460and
HT29 cells with 3:1, 1:1 and 1:3 co-culture ratios (NCM460 versus HT29) in cell number.
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very few in CM, and cell viability was sufficient to detect
protein secretion level in conditioned cultures. Furthermore,
the expression and distribution of acrogranin were also
determined in NCM460 and HT29 cells by immunostaining
assay. Acrogranin showed reductive expression around cell
nucleus in HT29 cells in co-cultured conditions, while a
strong expression of acrogranin was shown in whole cells in
separatelymono-cultured HT29 cells (Fig. 5E). However, there
was both weak expression of acrogranin in NCM460 cells
between mono-cultured and co-cultured system (Fig. 5D).
Acrogranin, usually overexpressed in various malignant
tumors [59], plays important roles in development and
wound repair [60]. Our results suggested that a high expres-
sion level of acrogranin in tumor cells would be inhibited by
their neighboringnormal epithelia,which is also supported that
stromal cells can suppress the oncogene expression to inhibit
tumor growth at an early stage of cancer progression [8].
In order to further explore intercellular protein communica-
tion between colon carcinoma cells and epithelia in different
tumor development phase, we further investigated the secre-
tion changes of acrogranin when NCM460 and HT29 cells were
co-culturedwithdifferent ratios of cell number. 80 μg of proteins
from CMwas used for western blot analysis. As the cell numberratio of NCM460 versus HT29 was 3:1, which represented
epithelia were dominated in tumor microenvironment in the
early origination stage of colon cancer, the secretion level of
acrogranin in the co-cultured CM was much lower than that in
1:1 co-culture of NCM460 and HT29 (Fig. 5F, lane 1–2). On the
contrary, as cell number ratio of NCM460 versus HT29 was 1:3,
meaning an advanced stage of colon cancer, the secreted
acrogranin was obviously elevated in co-cultured CM (Fig. 5F,
lane 2–3). These data indicated that an important step of
tumorigenesis is malignant transformation of normal epithelial
cells, which is induced via proteins secreted by adjacent tumor
cells [13]. In combination with the secretion level of acrogranin
in the early, middle and advanced development stages of colon
cancer, we can conclude that cellular communications between
malignant tumors and normal epithelial cells are interacted
complicatedly andchangeddynamically via secretedproteins to
impact relevant biological processes.
3.4.2. The expression of vimentin in co-cultures
Although vimentin was also largely decreased in co-cultured
CM (NCM460:HT29) than the CMmixture of two mono-cultures
(NCM460 + HT29) (P < 0.05) (Fig. 6A–B), the downregulation of
this protein in co-culture was mainly due to its reduced
expression in NCM460 cells (Fig. 6D). It was very also obvious
Fig. 6 – The expression level of vimentin in co-cultures. (A) ELISA analysis of vimentin in the CM from co-culture model and
mono-cultured NCM460 and HT29. (B) The secretion of vimentin was detected by western blot. 20 μg of proteins extracted from
mono-cultured or co-cultured CMwas loaded in each lane. (C) The expression of vimentin was detected bywestern blot. 20 μg of
proteins extracted from cell lysates, collected frommono-cultured or co-cultured NCM460 and HT29 respectively was loaded in
each lane. (D) The expression and location of vimentin (green) in mono-cultured NCM460 and co-cultured one in phase-contrast
microscopy image. (E) The expression and location of vimentin (green) in mono-cultured HT29 and co-cultured one in
phase-contrast microscopy image. (F) The secretion of vimentin was detected by western blot. 80 μg of proteins extracted from
co-culture CM in the condition of NCM460 co-cultured with HT29 with three different cell number mixed ratios as 3:1, 1:1 and 1:3
were loaded in each lane.
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mono-cultured CM of NCM460 cells (P < 0.05), but it was higher
than mono-cultured HT29 (P < 0.05) (Fig. 6A–B). Similarly, the
expression of vimentin was decreased from high level to low
degree in cell lysates of NCM460 between mono-culture and
co-culture (Fig. 6C, lane 1–2). Cell fluorescence analysis also
validated the expression changes of vimentin (Fig. 6D), while its
expression was little either in mono-cultured or in co-cultured
HT29 cells (Fig. 6C, lane 3–4; Fig. 6E). All results above were
consistentwith theMSquantificationdata. As shown inTable 1,
the SILAC ratio1 of vimentinwas 3.78,which showed that itwas
highly expressed in mono-cultured NCM460 cells compared
with co-cultured model. And its SILAC ratio2 was 0.28, this
meant vimentin rarely existed in mono-cultured HT29 cells.
Following, under the condition of modulating different
development stage of colon cancer in vitro, the expression
level of vimentin in co-culture model was dynamic along with
different co-culture ratios in cell number. Vimentin was
strongly expressed as 1:1 cell number ratio (NCM460/HT29),
whereas its secretion was weak with 3:1 or 1:3 co-culture ratio
(Fig. 6F). As a fact, it is a high expression level of vimentin in
NCM460 cells, while lower expression exists in colon cancer
cell line HT29 (Fig. 6C, lane 1, 3). This expression difference is
also existed in Hela and MCF-7 cells, two epithelial cancer
cell lines, which is due to a double AP1/jun-binding site that
mediates vimentin expression [61]. The endogenous expressiondifference of vimentin between NCM460 and HT29 cells can
account for the downregulated secretion level under 1:1
co-culture. And compared with 1:1 co-cultured ratio between
NCM460 and HT29 cells, the total secretion of vimentin was
both decreased with 1:3 or 3:1 co-culture ratio. As known,
vimentin, a biomarker of EMT [26], is transiently associated
with, and could be functionally involved in, themigratory status
of human epithelial cells [62]. Therefore, the expression level of
vimentin is always changed in the occurrence anddevelopment
steps of colon tumor as well as the EMT stage, which is affected
through tumor microenviroment, including epithelia, tumor
cells and other secreted proteins.
3.4.3. IGFBP6 expression in co-cultured conditions
IGFBP6 was another significantly changed protein in a
co-culture. Its SILAC ratio1 and ratio2 were 0.01 (NCM460/
co-culture) and 12.32 (HT29/co-culture) respectively, which
indicated over 10-fold of down-regulation in the co-culture
(Table 1). This MS quantification indicated that IGFBP6 was
mainly present in CM of mono-cultured HT29 cells, but weakly
expressed in the co-culturemodel andmono-cultured NCM460.
And the conclusion was also validated by ELISA and western
blot analysis (Fig. 7A–B). Immunofluorescence analysis was
further employed to confirm cell–cell interactions based on the
above results. Fluorescence intensity of IGFBP6 was very strong
in separately mono-cultured HT29 cells, but weak expression
Fig. 7 – The expression level of IGFBP6. (A) ELISA analysis of IGFBP6 in the CM from a co-culture and mono-cultured NCM460
and HT29 cells. (B) The secretion of IGFBP6 was detected by western blot. 20 μg of proteins extracted from mono-cultured or
co-cultured CM was loaded in each lane. (C) The expression and location of IGFBP6 (red) were shown in mono-cultured and
co-cultured NCM46 cells in phase-contrast microscopy image. (D) The expression and location of IGFBP6 (red) were shown in
mono-cultured and co-cultured HT29 cells in phase-contrast microscopy image.
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the biochemical data was highly consistent with the quantita-
tive secretome investigation by SILAC-based MS approach.
IGFBP6 was a component of IGF complex system which has
been reported to involve in the human cancer progression by
promoting cell proliferation and inhibiting cell apoptosis [63].
Meanwhile, IGFBP6 alsohas been reported asanoncosuppressor
in the cancer pathogenesis through regulating angiogenesis, cell
proliferation andmigration [64,65]. In our findings, a remarkable
decrease of IGFBP6 in 1:1 co-cultured system suggested that
cancer-associated signaling was probably suppressed by
normal epithelial cells to inhibit tumorigenesis in tumor
microenvironment at middle stage of colon cancer. In order to
understand whether IGFBP6 expression level was associated
with EMT that has been implicated in key stages of tumor
progression, whereby it facilitated epithelial cancer cell metas-
tasis, we compared cellular level of IGFBP6 between NCM460
and its EMT model cells, which were induced by continuous
stimulation with phorbol ester. As a result, IGFBP6 was located
in cell membrane and dramatically down-expressed in EMT
cells (Fig. 8A–B). The results indicated that IGFBP6 was tightly
associatedwith the development of EMT, but detail mechanism
of this protein involved in the occurrence and progression of
EMT should be further investigated.4. Discussion
Tumor microenvironment comprises neoplastic cells and
host stromal cells, and the latter includes fibroblasts, epithe-
lial cells, immune and inflammatory cells, adipocytes, glialcells, smooth muscle cells and resident or recruited vascular
cells [66]. The communications between tumor and stromal
cells are bidirectional and dynamic, the tumor and its stroma
co-evolve during tumor initiation and progression [2]. Co-
culture system has been widely used in many researches for
modulating various microenvironments [67]. For example, the
secretion of proteins was regulated to involve in various
biological events of cancer, including angiogenesis, inflam-
mation, cell proliferation and EMT in lung adenocarcinoma
[9]. The effect of interaction between fibroblasts and macro-
phages on MMP expression has also been well elucidated by a
co-culture system [68]. The normal epithelial cells, sitting on
the basementmembrane, are a first and primary barrier to fight
against tumors. Because of the complexity of cancer micro-
environment, we employed a co-culture system to modulate a
partially simplified tumor microenvironment and investigated
that secreted proteome mediated the interactions between
tumor cells and epithelia.
In our study, HT29 and NCM460 cells were co-cultured in
transwell-plates which separated the two cell lines by a
0.4 μm porous membrane but allowed bidirectional diffusion
of secreted proteins to affect each other. Because a low
abundance of the secreted proteins existed in culture medium
supernatants, the challenges in secretome research included
how to identify and quantify secreted proteins that are often
masked by high amounts of proteins in the culture medium
fidelity, how to remove contamination from serum or intracel-
lular proteins and so on. To address these obstacles and rule
out the contamination of serum proteins, cells for collecting
secreted proteins were cultured in serum-free medium and
washed three times with PBS. Meanwhile, in order to avoid
Fig. 8 – Analysis of the relationship between IGFBP6 and EMT. (A) The expression of IGFBP6 was detected in NCM460 and EMT
cells. 80 μg of proteins of cell lysates, collected from normal NCM460 and cells with EMT, was loaded in each lane. (B) The
expression and location of vimentin and IGFBP6 in normal NCM460 and EMT cells.
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normal medium until reaching 60%–70% confluency and then
replaced by serum-free medium. Proteins were extracted from
the supernatants, the level of cytosolic protein beta-actin in the
medium was used to monitor cell death by western blot assay.
As a result, beta-actin could not be detected in the supernatants
after 24 h or 48 h culture with serum-free medium, which
indicated that cell vitality was ensured to minimize the con-
tamination of released intracellular proteins due to cell death
and cell lysis.
It should be pointed out that even though we collected
proteins from CM, not all identified proteins belong to classical
secreted proteins with a signal peptide. In our experiment,
classical secreted proteins only accounted for about 20%, while
24% of the identified proteins in cell membrane were designat-
ed as shed proteins from cell surface, which was also regarded
as secreted proteins. Additionally, some of the identifiedproteins without signal peptide were functioned in cytoplasm,
but they still could be released out by non-classical or exosomal
pathways [10]. Along these lines, in the context of this study,
cytokeratin-9 and vimentin, without signal peptides, were also
classified as general secreted proteins [69].
We applied ‘single labeled’ SILAC approach to investigate
which proteins were secreted and regulated during co-culture.
The advantage of the experiment strategy based on SILAC
is that the multiple and complex secreted proteins can be
discriminated from which kinds of cells by the stable isotope
amino acid that had been incorporated. The different intensity
of peptides containing ‘light’ or ‘heavy’ isotope amino acid can
be easily detected by the mass spectrometry. In classical SILAC
experiment, equal amounts of proteins from two samples,
which are labeled with ‘heavy’ and ‘light’ isotope amino acid
respectively, are mixed to perform LC–MS/MS analysis [29]. But
as for the complexity and heterology of the secreted proteins
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for quantification standard instead of the same amounts of
proteins in our study.We found that total supernatant proteins
from the two groups of mono-cultured cells were proximately
same with their secreted proteins in a co-culture. Similarly,
Kurie JM group also employed equal number of cells for SILAC
quantification for secreted protein analysis and obtained
reliable results [9].
Understanding the interactions of different cells within
tumor microenvironment was critical for potential biomarker
selection, which can provide clue and target for cancer
biotherapy. Recently, it has reported that aspirin has pro-
foundly impact on patients with mutated-PI3KCA colon
cancer through inhibiting PI3K signaling activity [70]. And
some important factors including PTGS2, KRAS and phos-
phorylated AKT could be used as prognosis biomarkers for
colorectal cancer patient with aspirin as an adjuvant treat-
ment [70]. In our study, large numbers of proteins identified
and quantified are associated with tumor growth and spread,
some of which would be a candidate biomarker for diagnosis
and prognosis of colon cancer in future. In our study, as an
example, IGFBP6 is a key regulator of IGF mediated signal
transduction and exerts profound impact on cell fate [71].
Meanwhile IGFBP6 is also regarded as an oncosuppressor gene
in colon cancer [72] and nasopharyngeal carcinoma through
regulating EGR-1 expression [21]. IGFBP6 was found to be
down-regulated 10.8 fold by co-culturing NCM460 with HT29
from the results of SILAC quantification. Down-regulation of
IGFBP6 in co-culture medium was likely caused by decreasing
expression of the IGFBP6 in HT29. The expression pattern of
IGFBP6 in HT29 cells may be influenced by other secreted
factors derived from NCM460 during co-culturing. In addition,
IGFBP6 expression level is lower in EMT cells than the
epithelial cells. Due to pleiotropic functions of IGFBP6-
involved in IGF system [59], the roles and regulation mecha-
nism of IGFBP6 between NCM460 and HT29 will be investigat-
ed in the next stage. Therefore, using the co-culture system
with different mixing ratio of epithelia and tumor cells to
modulate tumorigenesis stage in vitro, the secretion change
of every single protein can be tracked to study cell–cell
communications, and finally give a new insight on the
biotherapy of cancer by inhibiting the key regulator during
the early stage of colon cancer.5. Conclusion
We identified a series of secreted proteins by a quantitative
SILAC proteomicsmethod in a co-culture between NCM460 and
HT29 cells, in which equal amounts of two kinds of cell lines
were co-cultured for simulating the middle development stage
of colon cancer. 45 proteins were altered over 2-fold in co-
cultured cellular supernatants compared with mono-cultured
conditions. These differential secreted proteins involve in
multiple tumor-associated biological functions including me-
tabolism, catabolic process, signal transduction, cell prolifera-
tion and apoptosis etc. The secretion level and acting pattern of
acrogranin, IGFBP6 and vimentin were changed along with
different co-cultured cell number ratios between NCM460 and
HT29 cells, simulating early, middle or advanced stage of coloncancer. Cellular communications betweenmalignant tumorous
and normal epithelial cells are interacted complicatedly and
changed dynamically via their secreted proteins to impact
relevant biological processes. Therefore, a quantitative prote-
ome profiling based on a co-culture system of NCM460 and
HT29 simplified complexity of cancer microenvironment in
vitro, also tracked secreted protein changes and their associated
biological roles between NCM460 and HT29 cells, which gives a
new insight on communications between tumor cells and
epithelia aswell as cancer biotherapy by inhibiting interactions.Author's contributions
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